MIM
MetLife Investment Management Portfolio holdings
AUM
$17B
1-Year Return
25.61%
This Quarter Return
+4.73%
1 Year Return
+25.61%
3 Year Return
+108.53%
5 Year Return
+194.13%
10 Year Return
–
AUM
$18.4B
AUM Growth
+$991M
(+5.7%)
Cap. Flow
+$649M
Cap. Flow
% of AUM
3.52%
Top 10 Holdings %
Top 10 Hldgs %
30.84%
Holding
2,900
New
51
Increased
2,117
Reduced
295
Closed
90
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$117M |
| 2 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
+$38.7M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$26.1M |
| 4 |
Apollo Global Management
APO
|
+$18.2M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$13.9M |
Top Sells
| 1 |
Arista Networks
ANET
|
+$14.8M |
| 2 |
Texas Pacific Land
TPL
|
+$5.28M |
| 3 |
Lennox International
LII
|
+$4.96M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$4.6M |
| 5 |
SWN
Southwestern Energy Company
SWN
|
+$4.05M |
Sector Composition
| 1 | Technology | 30.14% |
| 2 | Financials | 12.96% |
| 3 | Consumer Discretionary | 11.5% |
| 4 | Healthcare | 10.03% |
| 5 | Industrials | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Leslie's
LESL
$62M
| $212K | ﹤0.01% |
95,255
+5,539
| +6% | +$12.4K |
|
|
BCAX
2277
Bicara Therapeutics Inc. Common Stock
BCAX
$651M
| $212K | ﹤0.01% |
+12,163
| New | +$212K |
|
2278
RBB Bancorp
RBB
$333M
| $211K | ﹤0.01% |
10,315
+1,336
| +15% | +$27.4K |
|
2279
Corsair Gaming
CRSR
$929M
| $211K | ﹤0.01% |
31,956
+6,985
| +28% | +$46.2K |
|
2280
Luxfer Holdings
LXFR
$358M
| $211K | ﹤0.01% |
16,107
+2
| +0% | +$26 |
|
2281
Mineralys Therapeutics
MLYS
$2.99B
| $211K | ﹤0.01% |
17,124
| – | – |
|
2282
Regenxbio
RGNX
$483M
| $210K | ﹤0.01% |
27,189
| – | – |
|
|
CTV
2283
DELISTED
Innovid Corp.
CTV
| $210K | ﹤0.01% |
67,977
+37,307
| +122% | +$115K |
|
2284
Farmers & Merchants Bancorp
FMAO
$353M
| $210K | ﹤0.01% |
7,128
| – | – |
|
2285
Nu Skin
NUS
$570M
| $210K | ﹤0.01% |
30,429
+8,091
| +36% | +$55.7K |
|
2286
Kodiak Sciences
KOD
$513M
| $209K | ﹤0.01% |
+21,040
| New | +$209K |
|
2287
Treace Medical Concepts
TMCI
$442M
| $209K | ﹤0.01% |
28,046
| – | – |
|
2288
Rigel Pharmaceuticals
RIGL
$654M
| $206K | ﹤0.01% |
12,258
+2,014
| +20% | +$33.9K |
|
2289
Apellis Pharmaceuticals
APLS
$3.29B
| $205K | ﹤0.01% |
6,436
-146
| -2% | -$4.66K |
|
2290
8x8 Inc
EGHT
$285M
| $205K | ﹤0.01% |
76,854
+48,280
| +169% | +$129K |
|
2291
National Research Corp
NRC
$366M
| $205K | ﹤0.01% |
11,630
+2,592
| +29% | +$45.7K |
|
2292
Granite Ridge Resources
GRNT
$707M
| $204K | ﹤0.01% |
31,578
| – | – |
|
2293
Global Industrial
GIC
$1.44B
| $204K | ﹤0.01% |
8,215
+982
| +14% | +$24.3K |
|
2294
MasterCraft Boat Holdings
MCFT
$366M
| $203K | ﹤0.01% |
10,671
| – | – |
|
2295
AngioDynamics
ANGO
$445M
| $203K | ﹤0.01% |
22,140
+477
| +2% | +$4.37K |
|
2296
Distribution Solutions Group
DSGR
$1.43B
| $202K | ﹤0.01% |
5,886
| – | – |
|
2297
LSB Industries
LXU
$585M
| $202K | ﹤0.01% |
26,601
-3,844
| -13% | -$29.2K |
|
2298
Zillow
Z
$20.8B
| $202K | ﹤0.01% |
2,725
-53
| -2% | -$3.93K |
|
|
CBLL
2299
CeriBell, Inc. Common Stock
CBLL
$419M
| $201K | ﹤0.01% |
+7,749
| New | +$201K |
|
2300
Allient
ALNT
$774M
| $200K | ﹤0.01% |
8,255
| – | – |
|